CAPE is also reported to have an effect on breast cancer cells, with a similar IC50 value on the ER- and ER+ MDA-231 and MCF-7 cell lines, respectively, of 15 μM (4.26 μg/ml) [22]. The gene discussed is ESR1; the disease is breast cancer.